Literature DB >> 29030771

A bridge between evidence-based laboratory diagnostics and research in neuroimmunology: why standardizations and guidelines matter.

Diego Franciotta1, Antonio Uccelli2,3,4.   

Abstract

Keywords:  Anti-myelin oligodendrocyte glycoprotein antibodies; Autoantibodies; National healthcare system; Neurological autoimmune diseases; Statistics

Mesh：

Substances：

Year:  2017        PMID： 29030771     DOI： 10.1007/s10072-017-3022-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  18 in total

1.  How scientists fool themselves - and how they can stop.

Authors:  Regina Nuzzo
Journal:  Nature       Date:  2015-10-08       Impact factor: 49.962

2.  Pitfalls in the detection of N-methyl-d-aspartate-receptor (NMDA-R) antibodies.

Authors:  Matteo Gastaldi; Anaïs Thouin; Diego Franciotta; Angela Vincent
Journal:  Clin Biochem       Date:  2016-11-23       Impact factor: 3.281

3.  Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement.

Authors:  Mark S Freedman; Edward J Thompson; Florian Deisenhammer; Gavin Giovannoni; Guy Grimsley; Geoffrey Keir; Sten Ohman; Michael K Racke; Mohammad Sharief; Christian J M Sindic; Finn Sellebjerg; Wallace W Tourtellotte
Journal:  Arch Neurol       Date:  2005-06

4.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

Review 5.  Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

Authors:  M Andersson; J Alvarez-Cermeño; G Bernardi; I Cogato; P Fredman; J Frederiksen; S Fredrikson; P Gallo; L M Grimaldi; M Grønning
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

6.  Policy: NIH plans to enhance reproducibility.

Authors:  Francis S Collins; Lawrence A Tabak
Journal:  Nature       Date:  2014-01-30       Impact factor: 49.962

7.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.

Authors:  Sven Jarius; Klemens Ruprecht; Ingo Kleiter; Nadja Borisow; Nasrin Asgari; Kalliopi Pitarokoili; Florence Pache; Oliver Stich; Lena-Alexandra Beume; Martin W Hümmert; Corinna Trebst; Marius Ringelstein; Orhan Aktas; Alexander Winkelmann; Mathias Buttmann; Alexander Schwarz; Hanna Zimmermann; Alexander U Brandt; Diego Franciotta; Marco Capobianco; Joseph Kuchling; Jürgen Haas; Mirjam Korporal-Kuhnke; Soeren Thue Lillevang; Kai Fechner; Kathrin Schanda; Friedemann Paul; Brigitte Wildemann; Markus Reindl
Journal:  J Neuroinflammation       Date:  2016-09-26       Impact factor: 8.322

8.  Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases.

Authors:  Marie C Mayer; Constanze Breithaupt; Markus Reindl; Kathrin Schanda; Kevin Rostásy; Thomas Berger; Russell C Dale; Fabienne Brilot; Tomas Olsson; Dieter Jenne; Anne-Katrin Pröbstel; Klaus Dornmair; Hartmut Wekerle; Reinhard Hohlfeld; Brenda Banwell; Amit Bar-Or; Edgar Meinl
Journal:  J Immunol       Date:  2013-09-06       Impact factor: 5.422

9.  Why most published research findings are false.

Authors:  John P A Ioannidis
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.613

Review 10.  Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms.

Authors:  Sarosh R Irani; Jeffrey M Gelfand; Adam Al-Diwani; Angela Vincent
Journal:  Ann Neurol       Date:  2014-07-10       Impact factor: 10.422
View more
  1 in total

1.  Autoantibody Diagnostics in Neuroimmunology: Experience From the 2018 Italian Neuroimmunology Association External Quality Assessment Program.

Authors:  Matteo Gastaldi; Elisabetta Zardini; Silvia Scaranzin; Antonio Uccelli; Francesca Andreetta; Fulvio Baggi; Diego Franciotta
Journal:  Front Neurol       Date:  2020-01-14       Impact factor: 4.003
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.